LL-37 Product Brief

Ready-to-Sell Research Product Sheet

1. Compound Overview

LL-37 is a synthetic version of a naturally occurring human antimicrobial peptide derived from the cathelicidin protein (hCAP18).
It plays an important role in innate immune defense and has been widely studied for its antimicrobial, immunomodulatory, and tissue-repair signaling pathways.

LL-37 has attracted significant research interest in studies related to infection response, wound healing, skin regeneration, and immune system modulation.

2. Mechanism of Interest

LL-37 is studied for several biological mechanisms:

• Broad-spectrum antimicrobial activity against bacteria, viruses, and fungi
  • Modulation of innate immune system signaling
  • Influence on inflammatory cytokine pathways
  • Support of wound healing and tissue repair processes
  • Potential stimulation of angiogenesis and cellular migration

3. Research Areas Being Explored

• Antimicrobial peptide research
  • Immune system signaling studies
  • Wound healing and tissue repair models
  • Dermatological and skin regeneration research
  • Infection and inflammatory pathway studies

4. Suggested Research Vial Sizes

• 5 mg lyophilized vial
  • 10 mg lyophilized vial
  • 20 mg research vial
  • 50 mg laboratory vial

5. Example Reconstitution Chart

Example mixing protocols commonly used in research contexts:

5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL concentration

10 mg vial + 2 mL bacteriostatic water = 5 mg/mL concentration

20 mg vial + 4 mL bacteriostatic water = 5 mg/mL concentration

These concentrations allow accurate measurement using insulin syringes for laboratory research settings.

6. Label Information for Vials

• Compound name: LL-37
  • Total amount per vial (mg)
  • Lot / batch number
  • Manufacturing date
  • Storage instructions (2–8°C recommended)
  • Research use only disclaimer

7. Market Positioning

LL-37 is commonly positioned in the antimicrobial and immune-modulating research peptide category.

It is frequently associated with research exploring:

• Infection response models
  • Immune system modulation
  • Wound healing and skin repair studies
  • Antimicrobial signaling pathways

8. Example Research Stack Categories

• LL-37 + BPC-157
  • LL-37 + TB-500
  • LL-37 + KPV
  • LL-37 + regenerative peptide stacks

9. Safety and Regulatory Notes

LL-37 is not approved by the FDA for medical treatment and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.